ArticleCost effectiveness and resource allocation : C/E2014

A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer.

Panagiotis Petrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.